ZBTB43 inhibitors are a class of chemical compounds that specifically target ZBTB43, a transcription factor belonging to the ZBTB (zinc finger and BTB) protein family, which plays a significant role in regulating gene expression. ZBTB43 contains two key domains that define its function: the zinc finger domain, responsible for binding to specific DNA sequences, and the BTB (Broad-Complex, Tramtrack, and Bric-à-Brac) domain, which mediates protein-protein interactions. ZBTB43 is likely involved in transcriptional repression, binding to gene promoter regions and recruiting corepressors or chromatin-remodeling complexes via its BTB domain to modulate the transcription of target genes. Inhibitors of ZBTB43 function by disrupting either its DNA-binding ability or by interfering with the formation of transcriptional repression complexes, leading to altered gene expression profiles under its control.
The mechanisms of action of ZBTB43 inhibitors can vary depending on their chemical structure. One approach involves targeting the zinc finger domains, which are crucial for the protein's ability to recognize and bind specific DNA sequences. Inhibitors may chelate the zinc ions necessary for the structural stability of these motifs, thereby preventing ZBTB43 from binding to its target DNA regions. Without proper DNA binding, ZBTB43 cannot regulate the transcription of its target genes. Another mechanism involves interfering with the BTB domain, which is responsible for protein-protein interactions that allow ZBTB43 to recruit other regulatory proteins, such as corepressors or histone deacetylases, that are necessary for transcriptional repression. By inhibiting these interactions, ZBTB43 inhibitors block the assembly of transcriptional complexes, impairing the gene regulatory functions of the protein. The study of ZBTB43 inhibitors provides valuable insights into the broader mechanisms of transcriptional regulation and the role of zinc finger proteins in gene expression control, contributing to our understanding of how cellular processes are maintained at the genetic level.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A nucleoside analogue that can incorporate into DNA and RNA, leading to DNA demethylation and potentially affecting ZBTB43's gene regulatory functions. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
A histone deacetylase inhibitor that can increase histone acetylation levels, potentially counteracting the gene repression mediated by ZBTB43. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Another histone deacetylase inhibitor that can lead to changes in chromatin structure, potentially disrupting ZBTB43's binding to chromatin. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $128.00 $505.00 | 2 | |
A DNA methyltransferase inhibitor that can prevent DNA methylation, potentially altering ZBTB43's ability to regulate gene expression. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $52.00 $87.00 | 7 | |
An inhibitor of various enzymes, which can affect cellular processes, including gene regulation, potentially altering ZBTB43's activity. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
Can bind to DNA and interfere with transcription factor binding, potentially affecting ZBTB43's target gene expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
A DNA methyltransferase inhibitor that can lead to hypomethylation of DNA, potentially affecting the regulatory functions of ZBTB43. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $226.00 $846.00 | 1 | |
A BET bromodomain inhibitor that can displace bromodomain-containing proteins from chromatin, potentially affecting ZBTB43's interaction with chromatin. | ||||||
I-CBP112 | 1640282-31-0 | sc-507494 | 25 mg | $400.00 | ||
An acetyl-lysine competitive inhibitor that can affect the reading of acetylation marks, potentially influencing ZBTB43-mediated gene regulation. | ||||||
Chaetocin | 28097-03-2 | sc-200893 | 200 µg | $120.00 | 5 | |
A histone methyltransferase inhibitor that can alter histone methylation status, potentially affecting ZBTB43's function in gene expression. | ||||||